Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
All articles — 32007 total
WYNN enters September down 8.2% on the week and off nearly 9% over the past month, trading at $90.60 — a setup where options traders are turning noticeably more defensive while the Street's analyst consensus holds…
Tower Semiconductor heads into September having shed 6.4% on the week, with options traders abruptly turning more cautious and the CEO having banked a sizeable sum near the stock's recent peak. The sharpest signal this…
NVMI enters September with short sellers rebuilding positions at the fastest monthly pace in recent memory — all while the broader semiconductor equipment space suffers a sharp group-wide drawdown. The short interest…
Marvell Technology delivered results on August 27 that the market punished sharply, dropping 11.6% the next session — yet the analyst community responded by raising targets in near-unison, leaving the stock trading at…
Williams-Sonoma pulled back 5.4% on the week to $222.12, yet the more interesting story is the divergence between a softening price and a Street that spent the week upgrading its view of the stock. The analyst response…
Vertex Pharmaceuticals enters September with a notable upgrade from Wall Street's most closely watched desks — and options traders are finally moving in the same direction as the bulls. The standout event this week is…
Valero Energy closed September 1 at $361.99 — above the consensus analyst price target of $319.63 — putting the Street in the uncomfortable position of defending ratings on a stock that has already blown through their…
UnitedHealth Group ends the week essentially unchanged, but a quiet surface masks a slow-motion compression story: the stock is still trading at a steep discount to Street targets, multiples have drifted lower, and the…
United Therapeutics heads into the first week of September with short sellers retreating and options traders leaning modestly bullish — yet the dominant data point is a steady stream of planned CEO stock sales running…
Coherent Corp. enters September with a notable split in its setup: the stock dropped 5.6% on the week to $272.03, yet the Street grew more constructive, short sellers continued to cover, and a fresh initiating buy from…
Trex Company heads into September with a sharp weekly drawdown and a distribution shakeup debate dominating the bull-bear dialogue — yet the short-selling community has been quietly reducing exposure throughout the…
TEVA enters September with a quietly shifting short book, a 5% weekly price drop, and options traders showing their most defensive posture in months — all against a Street consensus that remains firmly bullish. The…
Telephone and Data Systems heads into September with a notable disconnect: short sellers have rebuilt positions sharply over the past month, yet the stock's lending market remains wide open and an activist sits…
STC heads into its October 21 earnings report trading below the Street's consensus target, with analyst sentiment cooling just as short sellers trim positions and options traders lean increasingly bullish. The most…
Southwest Airlines arrives at the start of September having shed 16% in a month and 7.7% in the past week alone, closing at $37.68 — yet the short book tells a surprisingly restrained story. The real action this week…
SLB enters September having delivered one of its stronger monthly performances in years, up 15% in August and 7% on the week — yet Tuesday's 4.9% single-day reversal to $57.15 cuts across that optimism sharply. The…
ROST enters September having given back most of its post-earnings gains, trading at $229.24 after sliding nearly 5% on the week — and options markets have noticed. The clearest signal this week is in derivatives…
Rockwell Automation enters September with a notable tension: options traders are the most defensively positioned they've been all year, while the Street's analysts just raised targets and borrow conditions remain…
REX American Resources enters September with a curious split: the stock nudged up 1.2% on the week to $41.99, yet the borrowing cost to short it has tripled in just five sessions — a sharp divergence that deserves…
Regeneron Pharmaceuticals heads into September with shorts retreating sharply and the Street lifting targets even as the consensus stays cautious. The most striking move this week is in short positioning. Bears have…
